Targeting survivin to overcome docetaxel resistance in prostate cancer

被引：0
|
作者：
Peery, Robert C. [1 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4396
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4396
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance
    Lim, Syer C.
    Jansson, Patric J.
    Assinder, Stephen J.
    Maleki, Sanaz
    Richardson, Des R.
    Kovacevic, Zaklina
    FASEB JOURNAL, 2020, 34 (09): : 11511 - 11528
  • [32] Targeting Metabolic Vulnerabilities to Overcome Prostate Cancer Resistance: Dual Therapy with Apalutamide and Complex I Inhibition
    Baumgartner, Valentin
    Schaer, Dominik
    Eberli, Daniel
    Salemi, Souzan
    CANCERS, 2023, 15 (23)
  • [33] Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
    Butler, Ethan B.
    Zhao, Yuhua
    Munoz-Pinedo, Cristina
    Lu, Jianrong
    Tan, Ming
    CANCER RESEARCH, 2013, 73 (09) : 2709 - 2717
  • [34] Overcoming docetaxel resistance in prostate cancer: a perspective review
    Hwang, Clara
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (06) : 329 - 340
  • [35] Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
    Kopczynska, Ewa
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (06): : 423 - 427
  • [36] Docetaxel Resistance in Prostate Cancer: Taking It Up a Notch
    Zhang, Tian
    Armstrong, Andrew J.
    CLINICAL CANCER RESEARCH, 2015, 21 (20) : 4505 - 4507
  • [37] Docetaxel nanoformulation reverts drug resistance in prostate cancer
    Nagesh, Prashanth K. B.
    Chowdhury, Pallabita
    Hatami, Elham
    Kashyap, Vivek K.
    Hafeez, Bilal B.
    Khan, Sheema
    Chauhan, Subhash C.
    Jaggi, Meena
    Yallapu, Murali M.
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy
    Wang, Shengpeng
    Xu, Yingqi
    Chan, Hon Fai
    Kim, Hae-Won
    Wang, Yitao
    Leong, Kam W.
    Chen, Meiwan
    JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 454 - 464
  • [39] Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
    Munoz-Galvan, Sandra
    Carnero, Amancio
    CELLS, 2020, 9 (06)
  • [40] Targeting survivin in cancer
    Altieri, Dario C.
    CANCER LETTERS, 2013, 332 (02) : 225 - 228
12345